Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Abbott

What to Expect From Abbott Laboratories' Q2 2025 Earnings Report

Abbott is poised to release its second-quarter results next month, and analysts project a single-digit earnings growth.

3 Dividend Growth Stocks To Buy and Hold Forever

3 Dividend Growth Stocks To Buy and Hold Forever

These three companies have a high 5-year dividend yield, providing long-term stability while maximizing income.

3 Dividend Aristocrats With Explosive Earnings and Bulletproof Payouts

3 Dividend Aristocrats With Explosive Earnings and Bulletproof Payouts

Discover 3 Dividend Aristocrats with high earnings growth, low payout ratios, and strong analyst ratings: perfect for long-term income investors.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector?

Abbott Laboratories has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.

The 3 Most Powerful Dividend Kings You’ve Probably Overlooked

These three Dividend Kings have strong cash flow and EPS growth, making a compelling case for long-term income investors.

How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals

Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.

Investors Business Daily

3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally

Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is Wall Street Bullish or Bearish on Abbott Laboratories Stock?

Is Wall Street Bullish or Bearish on Abbott Laboratories Stock?

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Wall Street’s Best-Kept Secret? These 3 Dividend Stocks Are Outperforming Big Tech

Wall Street’s Best-Kept Secret? These 3 Dividend Stocks Are Outperforming Big Tech

These three Dividend Kings are beating the market in 2025, offering strong yields, reliable growth, and solid analyst buy ratings.

MotoAmerica Revolutionises Rapid Concussion Testing in Sport With New Blood Test

MotoAmerica Revolutionises Rapid Concussion Testing in Sport With New Blood Test

The last time a helmet saved my life, I certainly wasn't feeling right for some time. I was dizzy, to say the least, but did I have a concussion? I don't know, and that's a problem in motorcycle racing. I continued to ride that day, but if I'd had Abbott's…

If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?

If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?

Medical stocks could see a resurgence if the economy hits a speed bump due to tariffs. But which health care stocks are worth watching?

Investors Business Daily

2025 Boston Marathon: Sharon Lokedi Shatters Course Record in Dominant Win

2025 Boston Marathon: Sharon Lokedi Shatters Course Record in Dominant Win

Lokedi broke the course record with a time of 2:17:22.

Sports Illustrated

Stock Market Tumbles On Nvidia Export Curbs, Fed Chief Powell, UnitedHealth: Weekly Review

Stock Market Tumbles On Nvidia Export Curbs, Fed Chief Powell, UnitedHealth: Weekly Review

The stock market sold off this week, with Nvidia AI chip export curbs, UnitedHealth guidance and Fed chief Jerome Powell's comments in focus.

Investors Business Daily

Tariff-Resistant Abbott Laboratories on Track for New Highs

Tariff-Resistant Abbott Laboratories on Track for New Highs

Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Abbott Makes A Bullish Move, Shrugging Off Covid Test Malaise

Abbott stock jumped Wednesday despite a mixed first-quarter report thanks to light sales of its Covid tests.

Abbott Elementary is Hulu's #3 most-watched show – here are 3 more comedies with over 90% on Rotten Tomatoes to stream

It's nearly the end of term for Abbott Elementary season 4, but school's in for these three comedies.

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report

Abbott Laboratories is expected to announce its first-quarter results this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Homes & Gardens

Jake Arnold's L.A.-meets-London outdoor collection with Crate & Barrel is giving me the motivation to springboard my new season patio makeover

When the inspo is this good, you want to buy into it immediately

Get all your
news in one place.

100’s of premium titles.
One news app.

Nearly 20 infant formulas found to contain toxic lead, arsenic, or both. Here's how parents can keep babies safe

“We really want these results to be empowering for parents,” said Consumer Reports, which tested 41 types of baby formula.

Is Abbott Laboratories Stock Outperforming the Dow?

Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects.

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

Investors Business Daily

Abbott Shrugs Off 'Middling' Quarter As 2025 Sales Guidance, Diabetes Tech Shine

Abbott stock reversed early losses Wednesday on its strong sales outlook for 2025 and a bullish performance from its diabetes devices.

Earnings Preview: What to Expect From Abbott's Report

Abbott will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

Love Dividends? 2 Passive Income Stocks to Scoop Up Now.

These consistent dividend-paying stocks could be a good addition to your portfolio.

How Abbott Labs Became a Dividend Growth Investor's Dream

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

People

122,881 stories

Mark Zuckerberg

Dylan Llewellyn

Brian Jordan Alvarez

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Rotten Tomatoes

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

281,291 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play